Future studies will need to unravel how cells coordinate the cholesterol transporter activities of NPC1, LAMP2 and LIMP2 when LDL-cholesterol supply is high and whether the cholesterol-binding activities of LAMPs and LIMP2 are relevant contributors to the pathophysiology of certain cancers. Here, SCARB2 is linked to cancer.